Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: Comprehensive case studies

Cell Transplantation

Volumn 17, Issue 12, 2008, Pages 1277-1293

  Geffner, L F ^a   Santacruz, P ^a   Izurieta, M ^a   Flor, L ^a   Maldonado, B ^b   Auad, A H ^a   Montenegro, X ^a   Gonzalez, R ^c   Silva, F ^c,d  

^a HOSPITAL LUIS VERNAZA   (Ecuador)

^b SOLCA   (Ecuador)

^c DaVinci Biosciences LLC   (United States)

^d DaVinci Biosciences   (United States)

Author keywords

Bone marrow stem cells (BMSCs); Quality of life; Spinal cord injury

Indexed keywords

CD34 ANTIBODY;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLADDER FUNCTION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SPINAL CORD INJURY; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; BONE MARROW CELLS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; QUALITY OF LIFE; SAFETY; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 62549145360     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908787648074     Document Type: Article

References (55)

1. Alessandri, G.; Pagano, S.; Bez, A.; Benetti, A.; Pozzi, S.; Iannolo, G.; Baronio, M.; Invernici, G.; Caruso, A.; Muneretto, C.; Bisleri, G.; Parati, E. Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364: 1872-1883; 2004.
2. Anderson, K. D. Targeting recovery: Priorities of the spinal cord-injured population. J. Neurotrauma 21:1371-1383; 2004.
3. Anderson, K. D.; Borisoff, J. F.; Johnson, R. D.; Stiens, S. A.; Elliott, S. L. The impact of spinal cord injury on sexual function: Concerns of the general population. Spinal Cord 45:328-337; 2007.
4. Aversa, F.; Martelli, M. F. Transplantation of haploidenti-cally mismatched stem cells for the treatment of malignant diseases. Springer Semin. Immunopafhol. 26:155-168; 2004.
5. Bjornson, C. R.; Rietze, R. L.; Reynolds, B. A.; Magli, M. C.; Vescovi, A. L. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo. Science 283:534-537; 1999.
6. Blatt, A.; Cotter, G.; Leitman, M.; Krakover, R.; Kaluski, E.; Milo-Cotter, O.; Resnick, I. B.; Samuel, S.; Gozal, D.; Vered, Z.; Slavin, S.; Shapira, M. Y. Intracoronary administration of autologous mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy. Am. Heart J. 150:986.el-986.e7; 2005.
7. Blight, A. R.; Tuszynski, M. H. Clinical trials in spinal cord injury. J. Neurotrauma 23:586-593; 2006.
8. Blight, A. R.; Young, W. Central axons in injured cat spinal cord recover electrophysiological function following remyelination by Schwann cells. J. Neurol. Sci. 91:15-34; 1989.
9. Bracken, M. B. Methylprednisolone in the management of acute spinal cord injuries. Med. J. Aust. 153:368; 1990.
10. Bracken, M. B.; Shepard, M. J.; Collins, W. F.; Holford, T. R.; Young, W.; Baskin, D. S.; Eisenberg, H. M.; Flamm, E.; Leo-Summers, L.; Maroon, J.; Marshall, L. F.; Perot, P. L.; Piepmeier, J. M.; Sonntag, V. K.; Wagner, F. C.; Wilberger, J. E.; Winn, H. R. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322:1405-1411; 1990.
11. Bracken, M. B.; Shepard, M. J.; Hellenbrand, K. G.; Collins, W. F.; Leo, L. S.; Freeman, D. F.; Wagner, F. C.; Flamm, E. S.; Eisenburg, H. M.; Goodman, J. H.; Perot, P. L.; Green, B. A.; Grossman, R. G.; Meagher, J. N.; Young, W.; Fischer, B.; Clifton, G. L.; Hunt, W. E.; Rif-kinson, N. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J. Neurosurg. 63:704-713; 1985.
12. Bracken, M. B.; Shepard, M. J.; Holford, T. R.; Leo-Summers, L.; Aldrich, E. F.; Fazl, M.; Fehlings, M.; Herr, D. L.; Hitchon, P. W.; Marshall, L. F.; Nockels, R. P.; Pascale, V.; Perot, Jr., P. L.; Piepmeier, J. M.; Sonntag, V. K.; Wagner, F.; Wilberger, J. E.; Winn, H. R.; Young, W. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. J. Am. Med. Assoc. 277:1597-1604; 1997.
13. + cells' migration into the injured site. Stem Cells Dev. 16:461-466; 2007.
14. Cardenas, D. D.; Ditunno, J.; Graziani, V.; Jackson, A. B.; Lammertse, D.; Potter, P.; Sipski, M.; Cohen, R.; Blight, A. R. Phase 2 trial of sustained-release fampridine in chronic spinal cord injury. Spinal Cord 45:158-168; 2007.
15. Chopp, M.; Zhang, X. H.; Li, Y.; Wang, L.; Chen, J.; Lu, D.; Lu, M.; Rosenblum, M. Spinal cord injury in rat: Treatment with bone marrow stromal cell transplantation. Neuroreport 11:3001-3005; 2000.
16. Clarke, D. L.; Johansson, C. B.; Wilbertz, J.; Veress, B.; Nilsson, E.; Karlström, H.; Lendahl, U.; Frisén, J. Generalized potential of adult neural stem cells. Science 288: 1660-1663; 2000.
17. Coleman, W. P.; Benzel, D.; Cahill, D. W.; Ducker, T.; Geisler, F.; Green, B.; Gropper, M. R.; Goffin, J.; Madsen, P. W.; Maiman, D. J.; Ondra, S. L.; Rosner, M.; Sasso, R. C.; Trost, G. R.; Zeidman, S. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J. Spinal Disord. 13:185-199; 2000.
18. Dumont, R. J.; Okonkwo, D. O.; Verma, S.; Hurlbert, R. J.; Boulos, P. T.; Ellegala, D. B.; Dumont, A. S. Acute spinal cord injury, part I: Pathophysiological mechanisms, & part II: Contemporary pharmacotherapy. Clin. Neuro-pharmacol. 24:254-279; 2001.
19. Emery, E.; Aldana, P.; Bunge, M. B.; Puckett, W.; Srini-vasan, A.; Keane, R. W.; Bethea, J.; Levi, A. D. Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 89: 911-920 1998.
20. Fassas, A. Autologous stem cell transplants in treatment of multiple sclerosis: Where we stand and future prospects. Int. J. Hematol. 76(Suppl. l):223-225; 2002.
21. Fawcett, J. W.; Curt, A.; Steeves, J. D.; Coleman, W. P.; Tuszynski, M. H.; Lammertse, D.; Bartlett, P. F.; Blight, A. R.; Dietz, V.; Ditunno, J.; Dobkin, B. H.; Havton, L. A.; Ellaway, P. H.; Fehlings, M. G.; Privat, A.; Grossman, R.; Guest, J. D.; Kleitman, N.; Nakamura, M.; Gavi-ria, M.; Short, D. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45:190-205; 2006.
22. Flanders, A. E.; Spettell, C. M.; Freidman, D. P.; Marino, R. J.; Herbison, G. J. The relationship between the functional abilities of patients with cervical spinal cord injury and the severity of damage revealed by MR imaging. Am. J. Neuroradiol. 20:926-934; 1999.
23. Garbossa, D.; Fontanella, M.; Fronda, C.; Benevello, C.; Muraca, G.; Vercelli, A. New strategies for repairing the injured spinal cord: The role of stem cells. Neurol. Res. 28:500-504; 2006.
24. Geisler, F. H.; Coleman, W. P.; Grieco, G.; Poonian, D. Sysgen Study Group 2001. The Sygen multicenter acute spinal cord injury study. Spine 26(Suppl. 24):S87-S98; 2001.
25. Gratama, J. W.; Keeney, M.; Sutherland, D. R. Enumeration of CD34 hematopoietic stem and progenitor cells. Curr. Prot. Cytometry 6.4.1-6.4.22; 1999.
26. He, T.; Smith, L. A.; Harrington, S.; Nath, K. A.; Caplice, N. M.; Katusic, Z. S. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 10:2378-2384; 2004.
27. Hess, D.; Li, L.; Martin, M.; Sakano, S.; Hill, D.; Strutt, B.; Thyssen, S.; Gray, D. A.; Bhatia, M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotech. 21:763-770; 2003.
28. Hofstetter, C. P.; Schwarz, E. J.; Hess, D.; Widenfalk, J.; El Manira, A.; Prockop, D. J.; Olson, L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. USA 99:2199-2204; 2002.
29. Hugenholtz, H. Methylprednisolone for acute spinal cord injury: Not a standard of care. Can. Med. Assoc. J. 168: 1145-1146; 2003.
30. Hurlbert, R. J. Methylprednisolone for acute spinal cord injury: An inappropriate standard of care. J. Neurosurg. 93(Suppl. l):l-7; 2000.
31. Iba, O.; Matsubara, H.; Nozawa, Y.; Fujiyama, S.; Amano, K.; Mori, Y.; Kojima, H.; Iwasaka, T. Angiogen-esis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106:2019-2025; 2002.
32. Jiang, Y.; Henderson, D.; Blackstad, M.; Chen, A.; Miller, R. F.; Verfaillie, C. M. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc. Natl. Acad. Sci. USA 100(Suppl. 1):11854-11860; 2003.
33. Kalka, C.; Masuda, H.; Takahashi, T.; Kalka-Moll, W. M.; Silver, M.; Kearney, M.; Li, T.; Isner, J. M.; Asahara, T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97:3422-3427; 2000.
34. Katz, R. T. Spasticity. In: O'Young, B.; Young, M. A.; Stiens, S. A., eds. PM&R secrets. Philadelphia: Hanley & Belfus; 1997:487.
35. Keirstead, H. S.; Nistor, G.; Bernal, G.; Totoiu, M.; Clout-ier, F.; Sharp, K.; Steward, O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25:4694-4705; 2005.
36. Kwon, B. K.; Tetzlaff, W.; Grauer, J. N.; Beiner, J.; Vaccaro, A. R. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 4:451-464; 2004.
37. Manginas, A.; Goussetis, E.; Koutelou, M.; Karatasakis, G.; Peristeri, I.; Theodorakos, A.; Leontiadis, E.; Plessas, N.; Theodosaki, M.; Graphakos, S.; Cokkinos, D. V. Pilot study to evaluate the safety and feasibility of intracoro-nary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction. Catheter Cardiovasc. Interv. 69:773-781; 2007.
38. Mautes, A. E. M.; Weinzierl, M. R.; Donovan, F.; Noble, L. J. Vascular events after spinal cord injury: Contribution to secondary pathogenesis. Phys. Ther. 80:673-687; 2000.
39. Murasawa, S.; Kawamoto, A.; Horii, M.; Nakamori, S.; Asahara, T. Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler. Thromb. Vasc. Biol. 25:1388-1394; 2005.
40. Nesathurai, S. Steroids and spinal cord injury: Revisiting the NASCIS 2 and NASCIS 3 trials. J. Trauma 45:1088-1093; 1998.
41. Ozbaran, M.; Omay, S. B.; Nalbantgil, S.; Kultursay, H.; Kumanlioglu, K.; Nart, D.; Pektok, E. Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. Eur. J. Cardio-thorac. Surg. 25:342-350; 2004.
42. Patel, A. N.; Geffner, L.; Vina, R. F.; Saslavsky, J.; Urschel, H. C.; Kormos, R.; Benetti, F. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: A prospective randomized study. J. Thorac. Cardiovasc. Surg. 130:1631-1638; 2005.
43. + progenitor cells modulate host angiogensis and inflammation in vivo. J. Mol. Cell. Cardiol. 41:86-96; 2006.
44. Shi, Q.; Rafii, S.; Wu, M. H.; Wijelath, E. S.; Yu, C.; Ishida, A.; Fujita, Y.; Kothari, S.; Mohle, R.; Sauvage, L. R.; Moore, M. A.; Storb, R. F.; Hammond, W. P. Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-367; 1998.
45. Skyler, J. S. Cellular therapy for type 1 diabetes: Has the üme come? J. Am. Med. Assoc. 297:1599-1600; 2007.
46. Steeves, J. D.; Fawcett, J.; Tuszynski, M. Report of international clinical trials workshop on spinal cord injury; February 20-21, 2004, Vancouver, Canada. Spinal Cord 42:591-597; 2004.
47. Steeves, J. D.; Lammertse, D.; Curt, A.; Fawcett, J. W.; Tuszynski, M. H.; Ditunno, J. F.; Ellaway, P. H.; Fehlings, M. G.; Guest, J. D.; Kleitman, N.; Bartlett, P. F.; Blight, A. R.; Dietz, V.; Dobkin, B. H.; Grossman, R.; Short, D.; Nakamura, M.; Coleman, W. P.; Gaviria, M.; Privat, A. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Clinical trial outcome measures. Spinal Cord 45:206-221; 2006.
48. Syková, E.; Homola, A.; Mazanec, R.; Lachmann, H.; Konrádová, S. L.; Kobylka, P.; Pádr, R.; Neuwirth, J.; Komrska, V.; Vávra, V.; Stulík, J.; Bojar, M. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant. 15:675-687; 2006.
49. Tator, C. H. Review of treatment trials in human spinal cord injury: Issues, difficulties, and recommendations. Neurosurgery 59:957-987; 2006.
50. Tator, C. H.; Duncan, E. G.; Edmonds, V. E.; Lapczak, L. I.; Andrews, D. F. Comparison of surgical and conser- vative management in 208 patients with acute spinal cord injury. Can. J. Neurol. Sci. 14:60-69; 1987.
51. Vaccaro, A. R.; Daugherty, R. J.; Sheehan, T. P.; Dante, S. J.; Cotler, J. M.; Balderston, R. A.; Herbison, G. J.; Northrup, B. E. Neurologic outcome of early versus late surgery for cervical spinal cord injury. Spine 22:2609-2613; 1997.
52. Voltarelli, J. C.; Couri, C. E.; Stracieri, A. B.; Oliveira, M. C.; Moraes, D. A.; Pieroni, F.; Coutinho, M.; Malme-grim, K. C.; Foss-Freitas, M. C.; Simões, B. P.; Foss, M. C.; Squiers, E.; Burt, R. K. Autologous nonmyeloabl ative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. J. Am. Med. Assoc. 297: 1568-1576; 2007.
53. Werner, N.; Junk, S. Laufs, U.; Link, A.; Walenta, K., Bohm, M.; Nickenig, G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 93:e17-24; 2003.
54. Zhang, Q.; She, M. Biological behaviour and role of endothelial progenitor cells in vascular diseases. Chin. Med. J. (Engl.) 120:2297-2303; 2007.
55. Zhang, Z.; Guth, L. Experimental spinal cord injury: Wal-lerian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration. Exp. Neurol. 147:159-171; 1997.